Avatar
Forbes News source @forbes.com 路 Jersey City, New Jersey 馃嚡馃嚜路 Jan 22

#AI #Biotechnology #DrugDiscovery

Link Preview
www.forbes.com
These AI Models Might Take Down Superbugs
In this week's edition of The Prototype, we look at using AI to find new drugs, quantum biotechnology, the ROI of generative AI and more.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#ArtificialIntelligence #DrugDiscovery #Oncology

Link Preview
www.nasdaq.com
InSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier
(RTTNews) - InSilico Medicine Cayman TopCo. (3696. HK), an artificial intelligence-driven drug discovery company, has announced a multi-year research and development collaboration valued at up to $888 million with France-based Servier for drug discovery and development in oncology.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#ArtificialIntelligence #DrugDiscovery #Oncology

Link Preview
www.nasdaq.com
InSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier
(RTTNews) - InSilico Medicine Cayman TopCo.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#Oncology #DrugDiscovery #AI

Link Preview
www.nasdaq.com
Insilico Medicine Announces US$888 Mln Multi-Year Oncology Collaboration With Servier
(RTTNews) - Insilico Medicine announced that it has entered into a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#Oncology #DrugDiscovery #AI

Link Preview
www.nasdaq.com
Insilico Medicine Announces US$888 Mln Multi-Year Oncology Collaboration With Servier
(RTTNews) - Insilico Medicine announced that it has entered into a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation.